
| Pair Name | Toosendanin, Paclitaxel | ||
| Phytochemical Name | Toosendanin (PubChem CID: 9851101 ) | ||
| Anticancer drug Name | Paclitaxel (PubChem CID: 36314 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Toosendanin, Paclitaxel | |||
| Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
| Biological Phenomena | Induction-->Endoplasmic reticulum stress | |||
| Gene Regulation | Down-regulation | Expression | CASP3 | hsa836 |
| Down-regulation | Expression | PARP1 | hsa142 | |
| Down-regulation | Expression | ADORA2A | hsa135 | |
| Up-regulation | Expression | CDH1 | hsa999 | |
| Down-regulation | Expression | CDH2 | hsa1000 | |
| Down-regulation | Expression | CTNNB1 | hsa1499 | |
| Down-regulation | Expression | SNAI1 | hsa6615 | |
| Down-regulation | Expression | TWIST1 | hsa7291 | |
| Down-regulation | Expression | VIM | hsa7431 | |
| In Vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 |
| BT-549 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_1092 | |
| 4T1 | Malignant neoplasms of the mouse mammary gland | Mus musculus (Mouse) | CVCL_0125 | |
| In Vivo Model | 2×10⁵ 4T1-fluc-red cells were inoculated in a mammary fat pat of each mouse. | |||
| Result | The results suggest that combination of TSN and PTX is superior to PTX alone, suggesting that it may be a promising alternative adjuvant chemotherapy strategy for patients with TNBC, especially those with metastatic TNBC. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Synergistic Anti-Tumor Effect of Toosendanin and Paclitaxel on Triple-Negative Breast Cancer via Regulating ADORA2A-EMT Related Signaling. Adv Biol (Weinh). 2023 Aug;7(8):e2300062. doi: 10.1002/adbi.202300062. | Click |